Fig. 5From: Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysisForest plot of comparison of treatment with MRAs versus without MRAs on hyperkalaemia. Two studies evaluated the risk of developing hyperkalaemia caused by MRAs in patients with DM and HF. The occurrence of hyperkalaemia in the MRA group was higher than in the comparison groupBack to article page